NBP256074PE

Novus Biologicals™ Heparan Sulfate Glucosamine 3-O-Sulfotransferase 3 Recombinant Protein Antigen

Manufacturer: Novus Biologicals™

Select a Size

Pack Size SKU Availability Price
Each of 1 NBP256074PE-Each-of-1 In Stock ₹ 31,372.50

NBP256074PE - Each of 1

₹ 31,372.50

In Stock

Quantity

1

Base Price: ₹ 31,372.50

GST (18%): ₹ 5,647.05

Total Price: ₹ 37,019.55

Gene ID (Entrez)

9953

Common Name

Heparan Sulfate Glucosamine 3-O-Sulfotransferase 3 Recombinant Protein Antigen

Formulation

PBS and 1M Urea, pH 7.4.

Gene Alias

h3-OST-3B, heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1

Label Type

Unlabeled

Quantity

100μL

Source

E.Coli

Purification Method

>80% by SDS-PAGE and Coomassie blue staining

Content And Storage

Store at −20°C. Avoid freeze-thaw cycles.

For Use With (Application)

Blocking/Neutralizing, Control

Gene Symbol

HS3ST3B1

Product Type

Recombinant Protein Antigen

Regulatory Status

RUO

Specific Reactivity

This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-50602. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml

Related Products

Img

Novus Biologicals™

NBP255930PE

--

Img

Novus Biologicals™

NBP256093PE

--

Img

Novus Biologicals™

NBP255354PE

--

Img

Novus Biologicals™

NBP256324PE

--

Img

Novus Biologicals™

NBP256211PE

--

Img

Novus Biologicals™

NBP255983PE

--

Img

Novus Biologicals™

NBP256495PE

--

Img

Novus Biologicals™

NBP256352PE

--

Description

  • A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human Heparan Sulfate Glucosamine 3-O-Sulfotransferase 3
  • Source: E.coli Amino Acid Sequence: LLLGSGSRAAHDPPALATAPDGTPPRLPFRAPPATPLASGKEMAEGAASPEEQSPEVPDSPSPISSFFSGSGSK The Heparan Sulfate Glucosamine 3-O-Sulfotransferase 3 Recombinant Protein Antigen is derived from E
  • coli
  • The Heparan Sulfate Glucosamine 3-O-Sulfotransferase 3 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.